Reuters logo
BRIEF-Guangdong Zhongsheng Pharmaceutical receives patent license
March 14, 2017 / 4:26 AM / 9 months ago

BRIEF-Guangdong Zhongsheng Pharmaceutical receives patent license

March 14 (Reuters) - Guangdong Zhongsheng Pharmaceutical Co Ltd :

* Says it received a patent license (No. ZL201310432986.5), for manufacturing method of ivabradine and its hydrochloride

* Patent valid for 20 years

Source text in Chinese: goo.gl/bSgPmb

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below